Harvey I. Pass, MD, Stephen E. Banner Professor of Thoracic Oncology, Vice-Chair Research, Department of Cardiothoracic Surgery, Division Chief, General Thoracic Surgery, NYU Langone Medical Center, discusses the challenges of treating patients with mesothelioma.

Mesothelioma is a notorious disease of elderly people, Pass says, and symptoms may go unnoticed or develop slowly. Additionally, a delay in treatment could arise. Pass says that only about 20% of patients with mesothelioma are seen that may be good surgical candidates for a multimodality treatment.

It remains important to find the disease earlier, when effective treatment may have a chance.

OncLive TV

® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers. 

Lung Cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

NYU Langone's Perlmutter Cancer Center

Cancer Centers

Partner

Harvey I. Pass, MD, from the NYU Langone Medical Center, discusses the challenges of treating patients with mesothelioma.


Dr. Pass on the Challenges of Treating Mesothelioma